in 100 - street Flashcards

1
Q
  • adenexal masses in pregnancy

- BPD in pregnancy

A

1 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Miraine tension type in pregnancy, proprtion

A

> 90 % of headaches in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

dura puncture in % of epidurals

A

0.5 - 2.5 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

headache in % accidental dural puncture

A

70 - 80 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cure rate for postdural puncture headache treated with blood patch

A

60 - 90 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

wound infection after emerency CS

A

10 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

postpartum psychosis if HX of bipolar disorder

A

25 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

postpartum psychosis if family HX

A

50 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

incidence of EOBS in eneral population in UK without screening

A

0.6 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

success of ECV in multip & primip

A

60 %

40 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

spontaneous version from breech to ceph in primip after 36 weeks

A

8 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ECV failed, spontaneous turn to cephalic

A

3 - 7 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

spontaneous reversion to breeh after successful ECV

A

3 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neonatal herpes incidence after primary and secondary

A

primary - 41 % VD

recurrent - 0-3 % VD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cell salvage recommended

A
  • Anticipated blood loss either induce anemia or

- >20 % of estimated blood volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Recurrence rate of AFLP

A

25 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risk of conenital heart block if mother has SLE with both anti-ro/la and recurrence

A
  • 2 - 3 % ( 18- 28 weeks)

- Recurrence in subsequent pregnancy - 16 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  • Lifetime risk of pelvic oran prolapse
  • Prolapse surery
  • Repeat surgery within 11 years
A
  • 8 - 12 %
  • 11 %
  • 11 %
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Risk of adhesion formation with midline incision

and low transverse

A
  • 50 %

- 23 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

primi opted for home delivery

  • hospital transfer
  • SVD
  • OVD
  • CS
  • Adverse neonatal outcome
A
  • 45 %
  • 80 %
  • 12.5 %
  • 8 %
  • 0.9 %
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

risk of SUI after VD & CS

A
  • 20 %

- 5 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

steroid resistant LS

A

77 %

- 4 - 10 % tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Risk of parvovirus transmission

  • < 15 %
  • 15 - 20 weeks
  • term
A
  • 15 %
  • 25 %
  • 70 %
24
Q

Sites pf perforation of uterus

A
  • Anterior: 40 %
  • CX canal: 36 %
  • RT lateral wall: 21 %
  • Left lateral wall: 17 %
  • Posterior wall & fundus: 13 %
25
Q
  • repeat surical ecvacuation &

- infection

A
  • 5 %

- 3 %

26
Q

CO- Patholoy with adenomyosis on US

A
  • Fibroid: 20.5 - 70 %
  • Endometriosis: 6.3 - 24 %
  • SIN: 1.4 - 19.8 %
  • Endometrial polyp: 2.3 -14.7 %
  • Endometrial hyperplasia: 7.3 - 13.6 %
  • Endometrial hyperplasia with atypia: 3.5 %
  • Adenocarinoma: 2.2 - 5.3 %
27
Q

Death or handicap of theMonozygotic, co-twin

A

occurs in 25% of cases.

28
Q

CS is associated with fetal laceration

A

1 - 2 %

29
Q

teratogenicity with AED

A
  • 2 or more drugs: 15 %
  • valproate , cabamazepam & phenytoin = 50 %
  • terato increases 6 fold: > 1 gm valproac acid per day
30
Q

cardiac output increase in pregnancy

A

40 %

from 4.5 L/min to 6 L/min

31
Q

stroke volume increase in pregnancy

A

30 %

32
Q

heart rate increase in pregnancy

A

10 %

33
Q

blood volume increase in pregnancy

A

30 %

34
Q

plasma volume increase in pregnancy

A

40 %

35
Q

expulsion after IUS insertion

A

5 % within 3 months

36
Q

ovarian cancer with BRCA 1 & 2

A

1: 35 - 40 %
2: 13 - 23 %

37
Q

Prophylactic oxytocic in 3rd stage of labour, reduce risk f of PPH

A

60 %

38
Q

Selective embryo reduction , risk of miscarriage

A

10 %

39
Q

CVS miscarriage

A

2 %

40
Q

Amniocentesis miscarriage

A

0.5 - 1 %

41
Q

Amniocentesis culture failure

A

0.5 %

42
Q

risk of a further molar pregnancy

A
is low (1/80): 1.25 %
98.75 %, no molar no obs complications
43
Q

If a further molar pregnancy does occur, in how much of

cases it will be of the same histological type.

A

68–80%

44
Q
  • cure rate for women with a score ≤ 6 :

- rate for women with score ≥ 7 :

A
  • almost 100%;

- 95%.

45
Q

Downs gentetics

A
  • Meiotic nondisjunction: 95 %
  • Robertsonian Translocation: 2 %
  • Mosaicism: 2 %
  • Chromosomal rearranement: 1%
46
Q

Downs & CHD %

A

40 -50 %

47
Q

Risk of recurrence of downs

A
  • If father carries Robertsonian translocation: <1 %
  • If mother carries Robertsonian translocation: 10 -15 %
  • If 2 affected fetuses: 10 %
48
Q

Risk of teratogenicity with anti-epileptic drug

A

Valproate 10.7/100
Poly therapy 16.8/100
N population 2.3/100

49
Q

In struma ovarii type of dermoid with active thyroid tissue. what % hyperthyroidism

A

10 %

50
Q

In cheicken pox, pneomonia %

A

10 %

51
Q

Varicella HX in UK

A

> 90 %

52
Q

infection risk, if patient declines prophylactic per operative antibiotics

A

8 - 10 %

53
Q

after radical hysterectomy , UV or UV fistula
which day
%

A

day 5 to 15

2 %

54
Q

placenta previa = risk of hysterectomy

A

11 %

55
Q

placenta previa +previous CS = risk of hysterectomy

A

27 %

56
Q

MRKH +Renal anamolies

A

40 % of MRKH